<DOC>
	<DOCNO>NCT02215629</DOCNO>
	<brief_summary>The main purpose study test safety efficacy VS-4718 two type leukemia patient find right dose VS-4718 future clinical trial . Other purpose study include : - Testing study drug VS-4718 level blood time happen study drug patient . - To find certain biomarkers leukemia patient predict 4718 study drug may may work .</brief_summary>
	<brief_title>Dose Escalation Study Acute Myeloid B-Cell Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Burkitt Lymphoma</mesh_term>
	<criteria>At least 18 year age Pathologic confirmation AML BALL Must relapse refractory AML BALL alternate therapy proven benefit ECOG status 0 1 Adequate renal function [ creatinine less equal 1.5x ULN ] GFR least 60mL/min Adequate hepatic function via total bilirubin , AST , ALT Corrected QT interval le 470 m ( via Fridericia correction formula ) Negative pregnancy test woman child bear potential Willingness use adequate birth control throughout participation men woman Diagnosis acute promyelocytic leukemia Active grade 2 high acute GVHD time study entry active chronic GVHD ( moderate severe ) Gastrointestinal condition could interfere swallow absorption study medication Diagnosis currently active CNS leukemia Known infection HIV AIDS ( test require ) Known active Hepatitis A , B C ( test require ) Patients actively treat secondary malignancy Cancerdirected therapy within 14 day first dose study drug 5 halflives , whichever long Major surgery within 28 day prior first dose study drug Use investigational drug within 28 day 5 halflives whichever long Women pregnant breastfeed Evidence uncontrolled infection require antibiotic therapy ; potential subject know suspected infection stable antibiotic therapy 72 hour may enrol Uncontrolled intercurrent illness include symptomatic congestive heart failure , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Acute Leukemia</keyword>
	<keyword>Relapsed Leukemia</keyword>
	<keyword>Refractory Leukemia</keyword>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>B-Cell Acute Lymphoblastic Leukemia</keyword>
</DOC>